Soojin Jang, ASA, MAAA

Consulting Actuary

PROFESSIONAL AFFILIATIONS

  • Associate of the Society of Actuaries
  • Member of the American Academy of Actuaries
  • Certified Health Consultant of the BlueCross BlueShield Association

EDUCATION

  • B.A., Mathematics
    University of California, Berkeley

Soojin Jang has been in the actuarial field since 2007.  Her career as a health actuary has been focused in pricing, valuation and risk adjustment over commercial, Medicare and Medicaid populations.  Prior to coming to consulting arena, she had been involved in and led data intensive analytics projects on payer side.  Her experience includes:

  • Assisting state regulatory authorities with risk-focused financial examinations of health insurance companies – MN, WI, CA, PA, NM.
  • Litigation consulting related to troubled health insurance companies in receivership; responsibilities include analyzing legal liability of outside actuarial consultants.
  • Consulting to employer groups with self-insured group medical insurance programs to assist them with the financial management of the plans; the scope of these engagements includes pricing, reserving, and the development of an employee contribution strategy.
  • Analyzing the financial impact of the Patient Protection and Affordable Care Act (PPACA) for employer groups and individuals.
  • Valuating the impacts of 3Rs – Risk Adjustment, Transitional Reinsurance and Temporary Risk Corridor, under PPACA, on behalf of a NY health insurer.
  • Strategizing risk score optimization and evaluating vendor/pilot programs performance.
  • Review of IBNP/IBNR reserve valuations for insurance companies and self-insured employers.
  • Year-over-year analyses of state run medical/Rx reinsurance reimbursement levels.
  • Conducting ROI analyses of revenue optimization strategies such as case management and vendor activities.
  • Maintaining actuarial models through system integration and upgrades, which included continuing validation of the model results.
  • Preparing NAIC and state regulatory filings on behalf of health insurers.
  • Developing HMO benefit adjustment factors as groups changed plan designs and quantifying financial impact, for a given rating year.
  • Analyses on regulatory changes and their projected impacts to pricing and/or accruals to be recorded in financial statements.